P

Inventor

MCALPINE JAMES B

US47 patents
⚠️ This page may combine multiple inventors who share the name “MCALPINE JAMES B”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ABBOTT LAB

35 patents
US5824513AOct 20, 1998

Recombinant DNA method for producing erythromycin analogs

ABBOTT LAB155 citations98
US5352806AOct 4, 1994

Taxol derivatives

ABBOTT LAB116 citations98
US5141926AAug 25, 1992

Erythromycin derivatives

ABBOTT LAB64 citations96
US6004787ADec 21, 1999

Method of directing biosynthesis of specific polyketides

ABBOTT LAB78 citations95
US5530020AJun 25, 1996

Taxol derivatives

ABBOTT LAB91 citations95
US5589485ADec 31, 1996

Dorrigocin antitumor agents

ABBOTT LAB94 citations94
US5149639ASep 22, 1992

Biologically pure cultures of streptomyces and use thereof in macrolide antibiotic production

ABBOTT LAB60 citations94
US4874748AOct 17, 1989

Cloning vectors for streptomyces and use thereof in macrolide antibiotic production

ABBOTT LAB70 citations94
US5594157AJan 14, 1997

Process for making taxol derivatives

ABBOTT LAB31 citations92
US5583115ADec 10, 1996

Dialkyltiacumicin compounds

ABBOTT LAB39 citations92
US4918174AApr 17, 1990

Tiacumicin compounds

ABBOTT LAB77 citations91
US5767096AJun 16, 1998

Bromotiacumicin compounds

ABBOTT LAB30 citations90
US5484799AJan 16, 1996

Antifungal dorrigocin derivatives

ABBOTT LAB25 citations90
US5773421AJun 30, 1998

Antifungal fusacandins

ABBOTT LAB21 citations89
US4189569AFeb 19, 1980

Seldomycin factor 5 derivatives

ABBOTT LAB7 citations73
US4187372AFeb 5, 1980

Seldomycin factor 5 derivative

ABBOTT LAB9 citations71
US5284947AFeb 8, 1994

Multiple drug resistance-attenuating compounds

ABBOTT LAB9 citations68
US4213971AJul 22, 1980

4-N, 2'-N and 4,2'-Di-N-fortimicin AD derivatives

ABBOTT LAB2 citations63
US4214076AJul 22, 1980

2'-N-Substituted fortimicin B and derivatives

ABBOTT LAB2 citations63
US4423210ADec 27, 1983

Intermediates for the preparation of 3-demethoxyfortimicins

ABBOTT LAB2 citations62
US4418193ANov 29, 1983

Method of producing 2-epi-fortimicin A

ABBOTT LAB3 citations62
US4282211AAug 4, 1981

1-Epi-2-deoxyfortimicin B and derivatives

ABBOTT LAB6 citations62
US4216210AAug 5, 1980

Fortimicins AM and AP derivatives

ABBOTT LAB3 citations62
US4208407AJun 17, 1980

5-Deoxyfortimicin A, 2,5-dideoxyfortimicin A and the corresponding 4-N-acyl and alkyl fortimicin B derivatives thereof and intermediates therefor

ABBOTT LAB2 citations62
US4207415AJun 10, 1980

Method of producing 2-deoxyfortimicin A

ABBOTT LAB3 citations62
US5585251ADec 17, 1996

Fungal isolates, fusacandins

ABBOTT LAB4 citations60
US5171740ADec 15, 1992

Coumamidine compounds

ABBOTT LAB3 citations58
US4223024ASep 16, 1980

4"-O-Alkylgentamicins and sagamicins

ABBOTT LAB4 citations58
US4226979AOct 7, 1980

Fortimicin AK

ABBOTT LAB1 citations52
US4272626AJun 9, 1981

Method of producing 1-epi-2-deoxyfortimicin A and intermediates therefor

ABBOTT LAB1 citations51
US4218442AAug 19, 1980

1-Epi-fortimicin A and derivatives

ABBOTT LAB1 citations51
US5192748AMar 9, 1993

Antibiotics unphenelfamycin and phenelfamycins A-D

ABBOTT LAB0 citations47
US4239752ADec 16, 1980

O-Demethylseldomycin factor 5 derivatives

ABBOTT LAB1 citations46
US4218441AAug 19, 1980

O-Demethylseldomycin factor 5

ABBOTT LAB0 citations46
US5356933AOct 18, 1994

Antifungal compounds

ABBOTT LAB0 citations44

THALLION PHARMACEUTICALS INC

6 patents

ECOPIA BIOSCIENCES INC

2 patents

PHYTERA INC

2 patents

ZAZOPOULOS EMMANUEL

1 patent

GEMIN X BIOTECHNOLOGIES

1 patent